Last reviewed · How we verify
Propranolol 0.2% eye drops
At a glance
| Generic name | Propranolol 0.2% eye drops |
|---|---|
| Sponsor | Meyer Children's Hospital IRCCS |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%) (PHASE2)
- a Prospective Cohort Study for Propranolol Treatment in Retinopathy of Prematurity (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |